Stephen G. Swisher, M.D., F.A.C.S.
Dr. Stephen G. Swisher is a thoracic and cardiovascular surgeon at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. As head of the Division of Surgery and professor of the Department of Thoracic and Cardiovascular Surgery, he plays an integral role in the care of patients diagnosed with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies and diseases. Dr. Swisher is also co-leader of the lung cancer initiative in its recently announced Moon Shots program.[1]
Dr. Swisher is consistently ranked among the top doctors and surgeons in Texas and the nation.
Education and Career
Dr. Swisher attended Stanford University as an undergraduate, graduating with a Bachelor of Arts degree in History and Biology. He graduated from the University of California at San Diego School of Medicine, then completed an internship and residency in General Surgery and a fellowship in Surgical Oncology at the University of California at Los Angeles. He also served as registrar in General Surgery at Nottingham University and completed a fellowship in Cardiothoracic Surgery at the University of Texas MD Anderson Cancer Center and St. Luke’s Episcopal Hospital/Texas Heart Institute in Houston, Texas.[1]
Following completion of his medical and education, Dr. Swisher remained at the University of Texas MD Anderson Cancer Center, serving as faculty in the Department of Virology Program and Department Chair of the Department of Thoracic and Cardiovascular Surgery.
Professional Memberships
Dr. Swisher is a member of several professional medical organizations and has served on numerous national and institutional committees. He is currently vice chair of the Lung Committee in SWOG, an NCI-supported cancer clinical trial cooperative group, and a member of the Lung Cancer Working Group of the American Society of Clinical Oncologists.[1]
He is also a member of:[1]
- Society of Surgical Oncology
- American Association for Thoracic Surgery
- American Surgical Association
- Society of Thoracic Surgeons
- International Society of Gastrointestinal Cancer
- American College of Surgeons Oncology Group
- General Thoracic Surgical Club
- American College of Surgeons
- Southern Thoracic Surgical Association
- American Board of Thoracic Surgery
- International Association for the Study of Lung Cancer
- Cooley Hands
- Denton A. Cooley Cardiovascular Society
- Texas Medical Association
- Harris County Medical Society
- Longmire Surgical Society
Research
Dr. Swisher has authored almost 300 peer-reviewed publications and is internationally recognized for his clinical trials investigating the use of gene therapy in lung and esophageal cancer using adenovirus-p53 and adenovirus-TNF a. He is working toward developing a novel small-molecule treatment for lung cancer and revealing the prognostic and therapeutic role of the biomarker PKR/eIF2 a. His research has been supported by the Department of Defense and the National Institutes of Health/National Cancer Institute.[1]
Some of Dr. Swisher’s recent peer-reviewed publications include:[1]
- Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Esophageal Adenocarcinoma Working Group, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg 162(5):1404-1412.e2, 2021. e-Pub 2020. PMID: 33010880.
- Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg 25(9):2185-2191, 2021. e-Pub 2021. PMID: 33555525.
- Pataer A, Weissferdt A, Vaporciyan AA, Correa AM, Sepesi B, Wistuba II, Heymach JV, Cascone T, Swisher SG. Evaluation of Pathologic Response in Lymph Nodes of Lung Cancer Patients Receiving Neoadjuvant Chemotherapy. J Thorac Oncol 16(8):1289-1297, 2021. e-Pub 2021. PMID: 33857666.
- Cascone T, Weissferdt A, Godoy MCB, William WN, Leung CH, Lin HY, Basu S, Yadav SS, Pataer A, Mitchell KG, Khan MAW, Shi Y, Haymaker C, Solis LM, Parra ER, Kadara H, Wistuba II, Sharma P, Allison JP, Ajami NJ, Wargo JA, Jenq RR, Gibbons DL, Lee JJ, Swisher SG, Vaporciyan AA, Heymach JV, Sepesi B. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nat Commun 12(1):5045, 2021. e-Pub 2021. PMID: 34413300.
